Smith Brendan - Insider Non-Derivative Transactions at CRISPR Therapeutics AG (CRSP) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 21, 2023, Smith Brendan's relationship to CRISPR Therapeutics AG (CRSP) is Officer (Chief Financial Officer) (Chief Financial Officer), and currently has 5,072 shares of Common Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CRSP insiders.
Data Source: SEC.
Smith Brendan - Insider Non-Derivative Transactions of CRSP Common Shares
Smith Brendan - Insider Non-Derivative Transactions at CRSP
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 22, 2023 | F -- (Common Shares) | 1,392 | 48.26 | 5,072 |
| Feb 19, 2023 | M -- (Common Shares) | 3,825 | 0 | 6,464 |
Items per page:
1 – 2 of 2